반응식
[CH:1]([C:4]1[CH:24]=[CH:23][C:7]([CH2:8][N:9]2[C:17]3[C:12](=[CH:13][C:14]([C:18]4[CH:19]=[N:20][NH:21][CH:22]=4)=[CH:15][CH:16]=3)[CH2:11][CH2:10]2)=[CH:6][CH:5]=1)([CH3:3])[CH3:2].Br[C:26]1C=C2C(=CC=1)NCC2.BrCC1C=CC(C(C)(C)C)=CC=1.CC1(C)C(C)(C)OB(C2C=NN(C(OC(C)(C)C)=O)C=2)O1>[Pd]>[C:1]([C:4]1[CH:5]=[CH:6][C:7]([CH2:8][N:9]2[C:17]3[C:12](=[CH:13][C:14]([C:18]4[CH:22]=[N:21][NH:20][CH:19]=4)=[CH:15][CH:16]=3)[CH2:11][CH2:10]2)=[CH:23][CH:24]=1)([CH3:26])([CH3:3])[CH3:2]참가 물질
6
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
1-(4-Isopropylbenzyl)-5-(1H-pyrazol-4-yl)indoline, 50 can be prepared by alkylation of 5-bromoindoline, 22 with 1-(bromomethyl)-4-(tert-butyl)benzene using the conditions described in Example 7, part 1 followed by palladium catalyzed coupling of the alkylation product with tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate, 10 followed by hydrolysis using the reaction conditions described in Example 8.
후처리
- customfollowed by hydrolysis
- customthe reaction conditions
출처 및 근거
- ORD 기록
- ord-34a0cdaace674f89aedd0d1f89de34d7
- 출처 데이터셋
- uspto-grants-2016_09
- 특허 번호
- US09447069B2
연결된 노트
불러오는 중…